Saptarshi Chatterjee

Author

Indian Institute of Science Education and Research Kolkata ORCID

Also Known As

Chatterjee, Saptarshi, Dr. Saptarshi Chatterjee, Saptarshi Chatterjee

Publications

243

Citations

H-Index

Concepts

All Affiliations

Indian Institute of Science Education and Research Kolkata Indian Institute of Science Bangalore

About

Saptarshi Chatterjee is an author at Indian Institute of Science Education and Research Kolkata specializing in oxidative stress, drug discovery, and medicinal chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	54
2	Natural Sciences	2	2	54
3	Biochemistry	2	2	54
4	Engineering	1	1	24
5	Chemical Biology	1	1	26

Saptarshi Chatterjee

Publications

157

Citations

H-Index

Page 1

	Year	Citations
Defect-Free Hyperbranched Polydithioacetal via Melt Polymerization Saptarshi Chatterjee, S. Ramakrishnan ACS Macro Letters	2012	35
Alteration of steric hindrance modulates glutathione resistance and cytotoxicity of three structurally related Ru<sup>II</sup>-p-cymene complexes Kallol Purkait, Saptarshi Chatterjee, Subhendu Karmakar, Dalton Transactions	2016	31
A hypoxia efficient imidazole-based Ru(<scp>ii</scp>) arene anticancer agent resistant to deactivation by glutathione Kallol Purkait, Subhendu Karmakar, Sudipta Bhattacharyya, Dalton Transactions Reductive StressRedox SignalingMedicinal ChemistryBiochemistryMedicine	2015	28
Anticancer activity of a cis-dichloridoplatinum(<scp>ii</scp>) complex of a chelating nitrogen mustard: insight into unusual guanine binding mode and low deactivation by glutathione Subhendu Karmakar, Kallol Purkait, Saptarshi Chatterjee, Dalton Transactions Medicinal ChemistryBiochemistryReactive Nitrogen SpecieMedicineNatural Sciences	2016	26
A novel photodegradable hyperbranched polymeric photoresist Saptarshi Chatterjee, S. Ramakrishnan Chemical Communications Materials SciencePristine HbpFirst SynthesisEngineeringPhotochemistry	2013	24
Evaluation of dose‐dependent treatment effects after mid‐trial dose escalation in biomarker, clinical, and cognitive outcomes for gantenerumab or solanezumab in dominantly inherited Alzheimer's disease Guoqiao Wang, Yan Li, Chengjie Xiong, Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring	2022	13

Page 1